ClinicalTrials.Veeva

Menu

Clinical Characteristics and Risk Factors for In-Hospital Mortality in Surgical Patients With Abdominal Sepsis

C

Chinese PLA General Hospital (301 Hospital)

Status

Completed

Conditions

Glucocorticoid
Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT06756750
PLAGH-AOC-L06

Details and patient eligibility

About

A retrospective study of sepsis patients with abdominal infections who underwent abdominal surgery was conducted in an attempt to reveal the epidemiological characteristics of sepsis after abdominal surgery, risk factors, and to analyze the prognosis of the patients, to reveal indicators of predictive value for the prognosis of patients with sepsis, with a view to providing certain evidence for optimizing the perianesthesia management of patients with sepsis.

Full description

Background and Aims: Abdominal sepsis refers to a severe and potentially life-threatening condition characterized by the presence of infection, inflammation, and tissue damage within the abdominal cavity. Glucocorticoids (GCs) play an important role in regulation of the host immune and inflammation responses involved in sepsis and surgery. This study aimed to investigate the potential impact of intraoperative GCs administration on the clinical outcome of surgical patients with abdominal sepsis.

Methods: This retrospective cohort study included a 1:1 propensity score-matched cohort of surgical patients afflicted with abdominal sepsis at 2 medical centers from January, 2008, through December, 2022. Patients were classified into low-GCs, high-GCs, and non-GCs groups according to the dosage of steroids used intraoperatively, and in-hospital mortality was designated as the primary outcome.

Enrollment

476 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Meeting the Sepsis 3.0 criteria ;
  • Patient's age ≥ 18 years;
  • Emergency or elective abdominal surgery.

Exclusion criteria

  • History of severe cardiopulmonary, hepatic, renal, or other organ damage;
  • Preoperative presence of infection other than abdominal;
  • Unplanned secondary surgery;
  • Receiving preoperative glucocorticoid therapy.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems